CureVac N.V. P/E Ratio

CureVac N.V. (CVAC) currently reports a P/E ratio of 4.38. That is below the Healthcare sector average of 70.94. Use the charts on this page to explore CureVac N.V.'s P/E ratio history and peer comparisons.

CureVac N.V.'s P/E ratio of 4.38 is lower than the Healthcare sector average of 70.94. That is roughly 93.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates CureVac N.V.'s market price to a fundamental measure such as earnings, sales, or book value. At 4.38, CVAC can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of 4.38, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 70.94. From there, open related valuation or income-statement pages for CureVac N.V., and consider following CVAC for alerts when major investors trade the stock.

CureVac N.V. is classified in the Healthcare sector. On P/E ratio, it currently shows 4.38 versus a sector average near 70.94. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CVAC with unrelated industries.